Currently Viewing:
Press Release

ASH 2017 Recap Now Available in Evidence-Based OncologyTM, a Publication of The American Journal of Managed Care®

Coverage from the Annual Meeting and Exposition of the American Society of Hematology, which took place December 9-12, 2017, in Atlanta, Ga., is available in a special recap issue of Evidence-Based Oncology™.
If you missed the American Society of Hematology (ASH) 2017, or you want to review major findings, the meeting recap is now available in Evidence-Based Oncology™, a publication of The American Journal of Managed Care® (AJMC®). You can find the full issue at

AJMC® Associate Editorial Director Surabhi Dangi-Garimella, PhD, leads off the issue with updates from the JULIET and ZUMA-1 trials, which led to approvals for the world’s first chimeric antigen receptor (CAR) T-cell therapies: Kymriah to treat pediatric acute lymphoblastic leukemia, and Yescarta to treat certain types of non-Hodgkin lymphoma. Both therapies are being studied in other blood cancers.

Dr. Dangi-Garimella also discusses a critical question in cancer care: as clinicians and patients balance the benefits and potential toxicities of therapies, when should treatment stop? This was addressed in the session, “Treatment-Free Remission and Cardiotoxicity: the Future of CML Care.”

Featured quality-of-life studies include:
  • an analysis of using of time spent at home at the end of life as a quality measure
  • a finding that low-income patients with AL amyloidosis had poorer health-related quality of life,
  • a connection between symptoms of myeloproliferative neoplasms and quality-of-life levels.
A study of rituximab use found that financial incentives may encourage overuse of the cancer drug in the community setting.

The issue features new results for ibrutinib, the ECHELON-1 study, additional coverage on the cost of care and a section on biosimilars. The issue also includes interviews with experts that also appear online at

About The American Journal of Managed Care®:

The American Journal of Managed Care® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care. is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care®, and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Jeff Prescott at 609-716-7777, ext. 331.


AJMC® Media:

Theresa Burek, 609-716-7777


Surabhi Verma

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!